Rhythm Pharmaceuticals (RYTM)
102.10
-0.56 (0.55%)
Upcoming Events
Latest Headlines
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
July 21, 2026 8:00 AM - StreetInsider
Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
July 14, 2026 4:13 AM - StreetInsider
Rhythm Pharmaceuticals TRANSCEND trial results published in NEJM
July 8, 2026 5:07 PM - StreetInsider
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
July 8, 2026 5:07 PM - StreetInsider
Rhythm Pharmaceuticals (RYTM) PT Raised to $141 at RBC Capital
July 7, 2026 8:00 AM - StreetInsider
Form 4 RHYTHM PHARMACEUTICALS, For: Jul 01 Filed by: Garfield Alastair
July 2, 2026 4:53 PM - SEC Filing
This biotech stock is on TD Cowen's best smidcap ideas list
July 1, 2026 12:00 PM - StreetInsider
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: JEAN CHRISTOPHE
June 25, 2026 6:10 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: MCGIRR DAVID W J
June 25, 2026 6:08 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: TETRAULT LYNN A.
June 25, 2026 6:07 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: Arbuckle Stuart A
June 25, 2026 6:03 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 23 Filed by: GOOD JENNIFER L
June 25, 2026 6:01 PM - SEC Filing
Form 8-K RHYTHM PHARMACEUTICALS, For: Jun 24
June 25, 2026 4:46 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: Jun 22 Filed by: TETRAULT LYNN A.
June 24, 2026 4:16 PM - SEC Filing
Form 144 RHYTHM PHARMACEUTICALS, Filed by: TETRAULT LYNN A.
June 22, 2026 4:50 PM - SEC Filing
Best Smidcap Ideas: TD Cowen Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)
June 17, 2026 9:19 AM - StreetInsider
Rhythm Pharmaceuticals (RYTM) PT Raised to $151 at Canaccord
June 16, 2026 6:36 AM - StreetInsider
Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens on Phase 2 Data
June 16, 2026 5:20 AM - StreetInsider
Form 8-K RHYTHM PHARMACEUTICALS, For: Jun 13
June 15, 2026 4:07 PM - SEC Filing
Rhythm Pharmaceuticals (RYTM) Announces Multiple New Data Presentations from MC4R Agonists
June 15, 2026 4:01 PM - StreetInsider
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
June 15, 2026 4:01 PM - StreetInsider
Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM) Post Release of Setmelanotide Data
June 15, 2026 9:31 AM - StreetInsider
Rhythm Pharmaceuticals (RYTM) PT Raised to $155 at Wells Fargo
June 15, 2026 7:21 AM - StreetInsider
Rhythm Pharmaceuticals reports positive Phase 2 data for PWS treatment
June 13, 2026 8:01 AM - StreetInsider
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
June 13, 2026 8:01 AM - StreetInsider
Rhythm Pharmaceuticals schedules call on Prader-Willi syndrome trial data
June 12, 2026 4:01 PM - StreetInsider
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
June 12, 2026 4:01 PM - StreetInsider
Rhythm Pharmaceuticals (RYTM) Reiterated at Market Outperform by Citizens
June 3, 2026 4:43 AM - StreetInsider
Form DEFA14A RHYTHM PHARMACEUTICALS,
May 29, 2026 4:10 PM - SEC Filing
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
May 29, 2026 8:00 AM - StreetInsider
Rhythm Pharmaceuticals Announces Publication of New Bardet-Biedl Syndrome Diagnostic Algorithm in the American Journal of Medical Genetics
May 28, 2026 8:00 AM - Globe NewsWire
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
May 26, 2026 8:00 AM - StreetInsider
Form 4 RHYTHM PHARMACEUTICALS, For: May 18 Filed by: Smith Hunter C
May 20, 2026 4:16 PM - SEC Filing
Form 4 RHYTHM PHARMACEUTICALS, For: May 15 Filed by: German Christopher Paul
May 19, 2026 4:16 PM - SEC Filing
Form SCHEDULE 13G/A RHYTHM PHARMACEUTICALS, Filed by: PERCEPTIVE ADVISORS LLC
May 15, 2026 4:00 PM - SEC Filing
Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology
May 12, 2026 8:00 AM - Globe NewsWire
Rhythm Pharmaceuticals (RYTM) PT Raised to $143 at Canaccord
May 7, 2026 6:39 AM - StreetInsider
Rhythm Pharmaceuticals (RYTM) PT Raised to $144 at Wells Fargo
May 6, 2026 8:43 AM - StreetInsider
Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference
May 6, 2026 8:00 AM - Globe NewsWire
Rhythm Pharmaceuticals (RYTM) PT Raised to $137 at RBC Capital
May 6, 2026 6:40 AM - StreetInsider
Form S-8 RHYTHM PHARMACEUTICALS,
May 5, 2026 4:29 PM - SEC Filing
Form DEFA14A RHYTHM PHARMACEUTICALS,
May 5, 2026 4:20 PM - SEC Filing
Form 10-Q RHYTHM PHARMACEUTICALS, For: Mar 31
May 5, 2026 4:16 PM - SEC Filing
Rhythm Pharmaceuticals (RYTM) PT Raised to $133 at Stifel
May 5, 2026 10:44 AM - StreetInsider
Form 8-K RHYTHM PHARMACEUTICALS, For: May 05
May 5, 2026 7:48 AM - SEC Filing
Rhythm Pharmaceuticals (RYTM) Reports In-Line Q1 EPS, provides guidance
May 5, 2026 7:10 AM - StreetInsider
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
May 5, 2026 7:00 AM - Globe NewsWire
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
May 4, 2026 8:00 AM - StreetInsider
Rhythm Pharmaceuticals gets EU approval for obesity drug IMCIVREE
May 1, 2026 6:55 AM - StreetInsider
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothal
May 1, 2026 6:55 AM - Globe NewsWire
Form SCHEDULE 13G RHYTHM PHARMACEUTICALS, Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 12:56 PM - SEC Filing
Form ARS RHYTHM PHARMACEUTICALS, For: Dec 31
April 29, 2026 4:14 PM - SEC Filing
Form DEF 14A RHYTHM PHARMACEUTICALS, For: Jun 24
April 29, 2026 4:12 PM - SEC Filing
Full Article List
